|
CU22545A1
(es)
|
1994-11-18 |
1999-03-31 |
Centro Inmunologia Molecular |
Obtención de un anticuerpo quimérico y humanizado contra el receptor del factor de crecimiento epidérmico para uso diagnóstico y terapéutico
|
|
US4304777A
(en)
|
1979-08-30 |
1981-12-08 |
Sterling Drug Inc. |
6-(Pyridinyl)-3(2H)-pyridazinones and their use as cardiotonics
|
|
US4305943A
(en)
|
1980-04-28 |
1981-12-15 |
Sterling Drug Inc. |
4-Amino-6-(pyridinyl)-3(2H)-pyridazinones and their use as cardiotonics
|
|
US4943533A
(en)
|
1984-03-01 |
1990-07-24 |
The Regents Of The University Of California |
Hybrid cell lines that produce monoclonal antibodies to epidermal growth factor receptor
|
|
US4826835A
(en)
|
1985-10-23 |
1989-05-02 |
Rorer Pharmaceutical Corporation |
Pyridyl-pyridazinone and pyridyl-pyrazolinone compounds and their use in the treatment of congestive heart failure
|
|
WO1989008108A1
(en)
|
1988-02-23 |
1989-09-08 |
Rorer International (Overseas) Inc. |
Pyridyl-pyridazinone and pyridyl-pyrazolinone compounds and their use in the treatment of congestive heart failure
|
|
DE69025946T2
(de)
|
1989-09-08 |
1996-10-17 |
Univ Duke |
Modifikationen der struktur des egf-rezeptor-gens in menschlichen glioma
|
|
DE4127404A1
(de)
|
1991-08-19 |
1993-02-25 |
Thomae Gmbh Dr K |
Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
|
|
AU661533B2
(en)
|
1992-01-20 |
1995-07-27 |
Astrazeneca Ab |
Quinazoline derivatives
|
|
GB9314893D0
(en)
|
1993-07-19 |
1993-09-01 |
Zeneca Ltd |
Quinazoline derivatives
|
|
IL112249A
(en)
|
1994-01-25 |
2001-11-25 |
Warner Lambert Co |
Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
|
|
IL112248A0
(en)
|
1994-01-25 |
1995-03-30 |
Warner Lambert Co |
Tricyclic heteroaromatic compounds and pharmaceutical compositions containing them
|
|
US5654307A
(en)
|
1994-01-25 |
1997-08-05 |
Warner-Lambert Company |
Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
|
|
US5844092A
(en)
|
1994-03-18 |
1998-12-01 |
Genentech, Inc. |
Human TRK receptors and neurotrophic factor inhibitors
|
|
US5877016A
(en)
|
1994-03-18 |
1999-03-02 |
Genentech, Inc. |
Human trk receptors and neurotrophic factor inhibitors
|
|
PT706799E
(pt)
|
1994-09-16 |
2002-05-31 |
Merck Patent Gmbh |
Imunoconjugados ii
|
|
GB9508538D0
(en)
|
1995-04-27 |
1995-06-14 |
Zeneca Ltd |
Quinazoline derivatives
|
|
US5747498A
(en)
|
1996-05-28 |
1998-05-05 |
Pfizer Inc. |
Alkynyl and azido-substituted 4-anilinoquinazolines
|
|
PL188959B1
(pl)
|
1995-07-06 |
2005-05-31 |
Novartis Ag |
Pirolopirymidyny i sposoby ich wytwarzania
|
|
US5760041A
(en)
|
1996-02-05 |
1998-06-02 |
American Cyanamid Company |
4-aminoquinazoline EGFR Inhibitors
|
|
GB9603095D0
(en)
|
1996-02-14 |
1996-04-10 |
Zeneca Ltd |
Quinazoline derivatives
|
|
CN100503580C
(zh)
|
1996-04-12 |
2009-06-24 |
沃尼尔·朗伯公司 |
酪氨酸激酶的不可逆抑制剂
|
|
US6391874B1
(en)
|
1996-07-13 |
2002-05-21 |
Smithkline Beecham Corporation |
Fused heterocyclic compounds as protein tyrosine kinase inhibitors
|
|
US6002008A
(en)
|
1997-04-03 |
1999-12-14 |
American Cyanamid Company |
Substituted 3-cyano quinolines
|
|
US6235883B1
(en)
|
1997-05-05 |
2001-05-22 |
Abgenix, Inc. |
Human monoclonal antibodies to epidermal growth factor receptor
|
|
RS49779B
(sr)
|
1998-01-12 |
2008-06-05 |
Glaxo Group Limited, |
Biciklična heteroaromatična jedinjenja kao inhibitori protein tirozin kinaze
|
|
CN1160338C
(zh)
|
1998-11-19 |
2004-08-04 |
沃尼尔·朗伯公司 |
N-[4-(3-氯-4-氟-苯基氨基)-7-(3-吗啉-4-基-丙氧基)-喹唑啉-6-基]-丙烯酰胺,不可逆的酪氨酸激酶抑制剂
|
|
IL153375A0
(en)
|
2000-06-22 |
2003-07-06 |
Genentech Inc |
Agonist anti-trk-c monoclonal antibodies
|
|
WO2004022540A2
(en)
|
2002-09-06 |
2004-03-18 |
Fujisawa Pharmaceutical Co., Ltd. |
Pyridazinone and pyridone derivatives as adenosine antagonists
|
|
ES2325440T3
(es)
|
2003-02-20 |
2009-09-04 |
Smithkline Beecham Corporation |
Compuestos de pirimidina.
|
|
MY141220A
(en)
|
2003-11-17 |
2010-03-31 |
Astrazeneca Ab |
Pyrazole derivatives as inhibitors of receptor tyrosine kinases
|
|
WO2005099363A2
(en)
|
2004-03-26 |
2005-10-27 |
Whitehead Institute For Biomedical Research |
Methods of diagnosing, preventing and treating cancer metastasis
|
|
EP1737841A1
(en)
|
2004-04-01 |
2007-01-03 |
Astellas Pharma Inc. |
Pyrazine derivatives and pharmaceutical use thereof as adenosine antagonists
|
|
US7696352B2
(en)
|
2004-06-18 |
2010-04-13 |
Millennium Pharmaceuticals, Inc. |
Factor Xa inhibitors
|
|
GB0512324D0
(en)
|
2005-06-16 |
2005-07-27 |
Novartis Ag |
Organic compounds
|
|
PE20060664A1
(es)
|
2004-09-15 |
2006-08-04 |
Novartis Ag |
Amidas biciclicas como inhibidores de cinasa
|
|
US20080090827A1
(en)
|
2004-11-30 |
2008-04-17 |
Artesian Therapeutics, Inc. |
Compounds With Mixed Pde-Inhibitory and Beta-Adrenergic Antagonist or Partial Agonist Activity For Treatment of Heart Failure
|
|
DE102005003687A1
(de)
|
2005-01-26 |
2006-07-27 |
Sphingo Tec Gmbh |
Immunoassay zur Bestimmung der Freisetzung von Neurotensin in die Zirkulation
|
|
CA2608009A1
(en)
|
2005-05-16 |
2006-11-23 |
Astrazeneca Ab |
Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors
|
|
ITRM20050290A1
(it)
|
2005-06-07 |
2006-12-08 |
Lay Line Genomics Spa |
Uso di molecole in grado di inibire il legame tra ngf e il suo recettore trka come analgesici ad effetto prolungato.
|
|
MY153898A
(en)
|
2005-06-22 |
2015-04-15 |
Plexxikon Inc |
Compounds and methods for kinase modulation, and indications therefor
|
|
KR101379693B1
(ko)
|
2005-08-25 |
2014-04-10 |
크리어빌리스 쎄라퓨틱스 에스.피.에이. |
K-252a 및 그의 유도체의 중합체 컨쥬게이트
|
|
HUE028588T2
(hu)
|
2005-12-13 |
2016-12-28 |
Incyte Holdings Corp |
Heteroaril-szubsztituált pirrolo[2,3-b]piridinek és pirrolo[2,3-b]pirimidinek mint Janus-kináz inhibitorok
|
|
AU2006325746A1
(en)
|
2005-12-14 |
2007-06-21 |
Bristol-Myers Squibb Company |
Six-membered heterocycles useful as serine protease inhibitors
|
|
ZA200808966B
(en)
|
2006-03-27 |
2010-03-31 |
Nerviano Medical Sciences Srl |
Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors
|
|
US20110008347A1
(en)
|
2006-12-01 |
2011-01-13 |
Agency For Science ,Technology And Research |
Cancer-related protein kinases
|
|
PE20121126A1
(es)
|
2006-12-21 |
2012-08-24 |
Plexxikon Inc |
Compuestos pirrolo [2,3-b] piridinas como moduladores de quinasa
|
|
WO2008079909A1
(en)
|
2006-12-21 |
2008-07-03 |
Plexxikon, Inc. |
Pyrrolo [2,3-b] pyridines as kinase modulators
|
|
RU2009122670A
(ru)
|
2006-12-21 |
2011-01-27 |
Плекссикон, Инк. (Us) |
Соединения и способы для модуляции киназ и показания к их применению
|
|
EA200900821A1
(ru)
|
2006-12-22 |
2010-02-26 |
Новартис Аг |
Производные 1-аминометил-l-фенилциклогексана как ингибиторы дпп-iv (дипептидилпептидазы-iv)
|
|
CN101679408B
(zh)
|
2006-12-22 |
2016-04-27 |
Astex治疗学有限公司 |
作为fgfr抑制剂的双环杂环化合物
|
|
BRPI0811516A2
(pt)
|
2007-05-04 |
2014-11-18 |
Irm Llc |
Compostos e composições como inibidores de c-kit e pdgfr cinase
|
|
DE102007025717A1
(de)
|
2007-06-01 |
2008-12-11 |
Merck Patent Gmbh |
Arylether-pyridazinonderivate
|
|
CL2008001709A1
(es)
|
2007-06-13 |
2008-11-03 |
Incyte Corp |
Compuestos derivados de pirrolo [2,3-b]pirimidina, moduladores de quinasas jak; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, psoriasis, artritis reumatoide, entre otras.
|
|
EP2740731B1
(en)
|
2007-06-13 |
2016-03-23 |
Incyte Holdings Corporation |
Crystalline salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
|
|
JP2010533158A
(ja)
|
2007-07-09 |
2010-10-21 |
アストラゼネカ アクチボラグ |
化合物類−945
|
|
JP2010533729A
(ja)
|
2007-07-17 |
2010-10-28 |
プレキシコン,インコーポレーテッド |
キナーゼ調節のための化合物と方法、及びそのための適応
|
|
BRPI0814441A2
(pt)
|
2007-07-19 |
2015-07-14 |
Schering Corp |
Compostos de amida heterocíclica como inibidores de proteína cinase
|
|
EA018503B1
(ru)
|
2007-07-20 |
2013-08-30 |
НЕРВИАНО МЕДИКАЛ САЙЕНСИЗ С.р.л. |
Замещенные производные индазола, активные как ингибиторы киназы
|
|
GB0720038D0
(en)
|
2007-10-12 |
2007-11-21 |
Astex Therapeutics Ltd |
New compounds
|
|
KR20100089851A
(ko)
|
2007-10-23 |
2010-08-12 |
노파르티스 아게 |
호흡기 질환의 치료를 위한 trkb 항체의 용도
|
|
EP2215091B1
(en)
|
2007-12-04 |
2016-03-30 |
Nerviano Medical Sciences S.r.l. |
Substituted dihydropteridin-6-one derivatives, process for their preparation and their use as kinase inhibitors
|
|
JP5420568B2
(ja)
|
2008-01-17 |
2014-02-19 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
改良された抗TrkB抗体
|
|
EP2254886B1
(en)
|
2008-03-28 |
2016-05-25 |
Nerviano Medical Sciences S.r.l. |
3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
|
CA2723237A1
(en)
|
2008-05-06 |
2009-11-12 |
Peter A. Blomgren |
Substituted amides, method of making, and use as btk inhibitors
|
|
PE20091846A1
(es)
|
2008-05-19 |
2009-12-16 |
Plexxikon Inc |
DERIVADOS DE PIRROLO[2,3-d]-PIRIMIDINA COMO MODULADORES DE CINASAS
|
|
US8158636B2
(en)
|
2008-05-19 |
2012-04-17 |
Plexxikon Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
|
EP2328586A2
(en)
|
2008-05-20 |
2011-06-08 |
Cephalon, Inc. |
Substituted pyridazinone derivatives as histamine-3 (h3) receptor ligands
|
|
AU2009248774B2
(en)
|
2008-05-23 |
2012-05-31 |
Novartis Ag |
Derivatives of quinolines and quinoxalines as protein tyrosine kinase inhibitors
|
|
CN104530052A
(zh)
|
2008-06-10 |
2015-04-22 |
普莱希科公司 |
用于激酶调节的5h-吡咯[2,3-b]吡嗪衍生物和其适应症
|
|
AU2009262068C1
(en)
|
2008-06-27 |
2015-07-02 |
Celgene Car Llc |
Heteroaryl compounds and uses thereof
|
|
JP2010013369A
(ja)
|
2008-07-01 |
2010-01-21 |
Astellas Pharma Inc |
ピラジン誘導体の製造法
|
|
CN102105151B
(zh)
|
2008-07-29 |
2013-12-18 |
内尔维阿诺医学科学有限公司 |
Cdk抑制剂在治疗神经胶质瘤中的应用
|
|
CA2732520A1
(en)
|
2008-08-05 |
2010-02-11 |
Merck Sharp & Dohme Corp. |
Therapeutic compounds
|
|
US8394802B2
(en)
|
2008-09-19 |
2013-03-12 |
Nerviano Medical Sciences S.R.L. |
3,4-dihydro-2H-pyrrolo[1,2-a]pyrazin-1-one derivatives for the modulation of the activity of protein kinases
|
|
SI2350075T1
(sl)
|
2008-09-22 |
2014-06-30 |
Array Biopharma, Inc. |
Substituirane imidazo (1,2b)piridazinske spojine kot Trk kinazni inhibitorji
|
|
CN102264736B
(zh)
|
2008-10-22 |
2013-08-14 |
阵列生物制药公司 |
作为TRK激酶抑制剂的取代的吡唑并[1,5-a]嘧啶化合物
|
|
WO2010056875A1
(en)
|
2008-11-12 |
2010-05-20 |
Cgi Pharmaceuticals, Inc. |
Pyridazinones and their use as btk inhibitors
|
|
US8912194B2
(en)
|
2008-11-24 |
2014-12-16 |
Nerviano Medical Sciences S.R.L. |
CDK inhibitor for the treatment of mesothelioma
|
|
PT2370413E
(pt)
|
2008-12-08 |
2015-10-23 |
Arena Pharm Inc |
Moduladores do recetor da prostaciclina (pgi2) úteis para o tratamento de distúrbios relacionados com o mesmo
|
|
JO3265B1
(ar)
|
2008-12-09 |
2018-09-16 |
Novartis Ag |
مثبطات بيريديلوكسى اندولات vegf-r2 واستخدامها لعلاج المرض
|
|
EP2196465A1
(en)
|
2008-12-15 |
2010-06-16 |
Almirall, S.A. |
(3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors
|
|
WO2010083283A2
(en)
|
2009-01-15 |
2010-07-22 |
Incyte Corporation |
Processes for preparing jak inhibitors and related intermediate compounds
|
|
WO2010111527A1
(en)
|
2009-03-26 |
2010-09-30 |
Plexxikon, Inc. |
Pyrazolo [ 3, 4 -b] pyridines as kinase inhibitors and their medical use
|
|
BRPI1012108B8
(pt)
|
2009-05-22 |
2021-05-25 |
Incyte Corp |
composto 3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il]octa no- ou heptano-nitrila, sua composição, seus usos e processo para preparar um sal de ácido fosfórico
|
|
EP3045457B1
(en)
|
2009-06-15 |
2018-05-09 |
Nerviano Medical Sciences S.r.l. |
Substituted pyrimidinylpyrrolopyridinone derivatives, process for their preparation and their use as kinase inhibitors
|
|
AR077468A1
(es)
|
2009-07-09 |
2011-08-31 |
Array Biopharma Inc |
Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
|
|
KR20120063515A
(ko)
|
2009-09-09 |
2012-06-15 |
아빌라 테라퓨틱스, 인크. |
Pi3 키나제 억제제 및 이들의 용도
|
|
EA021478B1
(ru)
|
2009-10-09 |
2015-06-30 |
Инсайт Корпорейшн |
ГИДРОКСИЛЬНЫЕ, КЕТО И ГЛЮКУРОНИДНЫЕ ПРОИЗВОДНЫЕ 3-(4-(7Н-ПИРРОЛО[2,3-d]ПИРИМИДИН-4-ИЛ)-1Н-ПИРАЗОЛ-1-ИЛ)-3-ЦИКЛОПЕНТИЛПРОПАННИТРИЛА
|
|
US7741330B1
(en)
|
2009-10-12 |
2010-06-22 |
Pharmacyclics, Inc. |
Pyrazolo-pyrimidine inhibitors of Bruton's tyrosine kinase
|
|
WO2011092120A1
(en)
|
2010-01-29 |
2011-08-04 |
Nerviano Medical Sciences S.R.L. |
6,7- dihydroimidazo [1,5-a] pyrazin-8 (5h) - one derivatives as protein kinase modulators
|
|
KR101483215B1
(ko)
|
2010-01-29 |
2015-01-16 |
한미약품 주식회사 |
단백질 키나아제 저해활성을 갖는 비시클릭 헤테로아릴 유도체
|
|
ES2594927T3
(es)
|
2010-02-18 |
2016-12-23 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Métodos para prevenir las metástasis cancerosas
|
|
TWI510487B
(zh)
|
2010-04-21 |
2015-12-01 |
Plexxikon Inc |
用於激酶調節的化合物和方法及其適應症
|
|
GB201007286D0
(en)
*
|
2010-04-30 |
2010-06-16 |
Astex Therapeutics Ltd |
New compounds
|
|
BR122019024201B1
(pt)
|
2010-05-20 |
2021-08-03 |
Array Biopharma Inc |
Composto macrocíclico como inibidores de trk quinase, seu uso, e composição farmacêutica
|
|
UY33597A
(es)
|
2010-09-09 |
2012-04-30 |
Irm Llc |
Compuestos y composiciones como inhibidores de la trk
|
|
WO2012034095A1
(en)
|
2010-09-09 |
2012-03-15 |
Irm Llc |
Compounds and compositions as trk inhibitors
|
|
GB201020179D0
(en)
|
2010-11-29 |
2011-01-12 |
Astex Therapeutics Ltd |
New compounds
|
|
EP2668188B1
(en)
|
2011-01-26 |
2016-05-18 |
Nerviano Medical Sciences S.r.l. |
Tricyclic derivatives, process for their preparation and their use as kinase inhibitors
|
|
US8975267B2
(en)
|
2011-01-26 |
2015-03-10 |
Nerviano Medical Sciences S.R.L. |
Tricyclic pyrrolo derivatives, process for their preparation and their use as kinase inhibitors
|
|
PE20141360A1
(es)
|
2011-02-07 |
2014-10-13 |
Plexxikon Inc |
Compuestos y metodos para la modulacion de quinasas e indicaciones para los mismos.
|
|
JP5620417B2
(ja)
|
2011-02-07 |
2014-11-05 |
中外製薬株式会社 |
アミノピラゾール誘導体を含む医薬
|
|
US9199979B2
(en)
|
2011-02-24 |
2015-12-01 |
Nerviano Medical Sciences S.R.L. |
Thiazolylphenyl-benzenesulfonamido derivatives as kinase inhibitors
|
|
BR112013021638A2
(pt)
|
2011-02-25 |
2016-08-02 |
Irm Llc |
"compostos inibidores de trk, seu uso e composições que os compreendem"
|
|
US9284298B2
(en)
|
2011-04-11 |
2016-03-15 |
Nerviano Medical Sciences S.R.L. |
Pyrazolyl-pyrimidine derivatives as kinase inhibitors
|
|
RU2621732C2
(ru)
|
2011-04-19 |
2017-06-07 |
НЕРВИАНО МЕДИКАЛ САЙЕНСИЗ С.р.л. |
Замещенные пиримидинилпирролы, активные в качестве ингибиторов киназы
|
|
EA023579B1
(ru)
|
2011-05-12 |
2016-06-30 |
НЕРВИАНО МЕДИКАЛ САЙЕНСИЗ С.р.л. |
Замещенные производные индазола, активные в качестве ингибиторов киназы
|
|
NZ618795A
(en)
|
2011-05-13 |
2015-07-31 |
Array Biopharma Inc |
Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as trka kinase inhibitors
|
|
EP2736514B1
(en)
|
2011-07-28 |
2017-10-18 |
Nerviano Medical Sciences S.r.l. |
Alkynyl substituted pyrimidinyl-pyrroles active as kinases inhibitors
|
|
JP6036693B2
(ja)
|
2011-08-05 |
2016-11-30 |
アステラス製薬株式会社 |
新規fgfr4変異体の検出法
|
|
KR20140052032A
(ko)
|
2011-08-17 |
2014-05-02 |
에프. 호프만-라 로슈 아게 |
브루톤 티로신 키나아제의 억제제
|
|
ES2660265T3
(es)
|
2011-10-07 |
2018-03-21 |
Nerviano Medical Sciences S.R.L. |
Derivados de 3,4-dihidropirrolo[1,2-a]pirazin-1(2h)-ona 4-alquil-sustituidos como inhibidores de cinasa
|
|
WO2013050446A1
(en)
|
2011-10-07 |
2013-04-11 |
Nerviano Medical Sciences S.R.L. |
SUBSTITUTED 3,4-DIHYDROPYRROLO[1,2-a]PYRAZIN-1(2H)-ONE DERIVATIVES AS KINASES INHIBITORS
|
|
GB201118656D0
(en)
|
2011-10-28 |
2011-12-07 |
Astex Therapeutics Ltd |
New compounds
|
|
GB201118654D0
(en)
*
|
2011-10-28 |
2011-12-07 |
Astex Therapeutics Ltd |
New compounds
|
|
UA111756C2
(uk)
|
2011-11-03 |
2016-06-10 |
Ф. Хоффманн-Ля Рош Аг |
Сполуки гетероарилпіридону та азапіридону як інгібітори тирозинкінази брутона
|
|
US8669251B2
(en)
|
2011-11-03 |
2014-03-11 |
Genentech, Inc. |
8-fluorophthalazin-1(2H)-one compounds
|
|
AU2012339753A1
(en)
|
2011-11-14 |
2014-06-19 |
Tesaro, Inc. |
Modulating certain tyrosine kinases
|
|
US9133328B2
(en)
|
2011-12-12 |
2015-09-15 |
Sa Des Eaux Minerales D'evian Saeme |
Plastic compositions and containers made thereof
|
|
US8377946B1
(en)
|
2011-12-30 |
2013-02-19 |
Pharmacyclics, Inc. |
Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors
|
|
PE20150666A1
(es)
|
2012-03-01 |
2015-05-06 |
Array Biopharma Inc |
Inhibidores de serina/treonina cinasa
|
|
ES2605388T3
(es)
|
2012-04-26 |
2017-03-14 |
Ono Pharmaceutical Co., Ltd. |
Compuesto inhibidor de Trk
|
|
US9254288B2
(en)
|
2012-05-07 |
2016-02-09 |
The Translational Genomics Research Institute |
Susceptibility of tumors to tyrosine kinase inhibitors and treatment thereof
|
|
NZ703124A
(en)
|
2012-05-23 |
2016-07-29 |
Nerviano Medical Sciences Srl |
Process for the preparation of n-[5-(3,5-difluoro-benzyl)-1h-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide
|
|
GB201209613D0
(en)
|
2012-05-30 |
2012-07-11 |
Astex Therapeutics Ltd |
New compounds
|
|
TWI585088B
(zh)
|
2012-06-04 |
2017-06-01 |
第一三共股份有限公司 |
作爲激酶抑制劑之咪唑并[1,2-b]嗒衍生物
|
|
CA2876689C
(en)
|
2012-06-13 |
2022-04-26 |
Incyte Corporation |
Substituted tricyclic compounds as fgfr inhibitors
|
|
NZ703495A
(en)
|
2012-07-11 |
2018-02-23 |
Blueprint Medicines Corp |
Inhibitors of the fibroblast growth factor receptor
|
|
BR112015001724A2
(pt)
|
2012-07-27 |
2018-04-03 |
Genentech Inc |
métodos de tratamento de condições relacionadas a fgfr3
|
|
CN104507923B
(zh)
|
2012-08-02 |
2018-02-09 |
内尔维阿诺医学科学有限公司 |
作为激酶抑制剂的取代的吡咯类活性剂
|
|
EP4223770A3
(en)
|
2012-11-05 |
2023-10-18 |
Foundation Medicine, Inc. |
Novel fusion molecules and uses thereof
|
|
EP2917214B1
(en)
|
2012-11-07 |
2019-08-28 |
Nerviano Medical Sciences S.r.l. |
Substituted pyrimidinyl and pyridinyl-pyrrolopyridinones, process for their preparation and their use as kinase inhibitors
|
|
US9828360B2
(en)
|
2012-11-13 |
2017-11-28 |
Array Biopharma Inc. |
Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
|
ME02990B
(me)
|
2012-11-13 |
2018-10-20 |
Array Biopharma Inc |
Jedinjenja n-pirolidinil, n'-pirazolil- uree, tiouree, guanidina i cijanoguanidina kао inhibitori trka kinaze
|
|
WO2014078325A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
N-(monocyclic aryl),n'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
US9822118B2
(en)
|
2012-11-13 |
2017-11-21 |
Array Biopharma Inc. |
Bicyclic heteroaryl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
|
WO2014078328A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
N-bicyclic aryl,n'-pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
WO2014078331A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
N-(arylalkyl)-n'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
WO2014078372A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
CA2891334C
(en)
|
2012-11-13 |
2021-10-19 |
Array Biopharma Inc. |
Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of pain
|
|
WO2014078417A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
Pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
US9981959B2
(en)
|
2012-11-13 |
2018-05-29 |
Array Biopharma Inc. |
Thiazolyl and oxazolyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
|
MX2015004626A
(es)
|
2012-11-29 |
2015-07-14 |
Yeda Res & Dev |
Metodos para prevenir metastasis de tumor, tratar y pronosticar cancer e identificar agentes que son inhibidores putativos de metastasis.
|
|
CA2898326C
(en)
|
2013-01-18 |
2022-05-17 |
Foundation Medicine, Inc. |
Methods of treating cholangiocarcinoma
|
|
JP6483624B2
(ja)
|
2013-02-07 |
2019-03-13 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung |
ピリダジノン−アミド誘導体
|
|
MX362181B
(es)
|
2013-02-19 |
2019-01-08 |
Ono Pharmaceutical Co |
Compuesto inhibidor de cinasa del receptor de tropomiosina (trk).
|
|
JP2016510751A
(ja)
|
2013-03-06 |
2016-04-11 |
ジェネンテック, インコーポレイテッド |
抗がん剤耐性を治療及び予防する方法
|
|
US9242969B2
(en)
|
2013-03-14 |
2016-01-26 |
Novartis Ag |
Biaryl amide compounds as kinase inhibitors
|
|
US9850038B2
(en)
|
2013-03-15 |
2017-12-26 |
Reynolds Presto Products Inc. |
Child resistant zipper closure for recloseable pouch with double slider and methods
|
|
WO2014160521A1
(en)
|
2013-03-15 |
2014-10-02 |
Blueprint Medicines Corporation |
Piperazine derivatives and their use as kit modulators
|
|
US8957080B2
(en)
|
2013-04-09 |
2015-02-17 |
Principia Biopharma Inc. |
Tyrosine kinase inhibitors
|
|
CN105431436B
(zh)
|
2013-05-14 |
2017-11-28 |
内尔维阿诺医学科学有限公司 |
吡咯并[2,3‑d]嘧啶衍生物,它们的制备方法和它们作为激酶抑制剂的用途
|
|
RU2015149937A
(ru)
|
2013-05-30 |
2017-07-06 |
Плексксикон Инк. |
Соединения для модулирования киназы и показания к их применению
|
|
HK1214820A1
(zh)
|
2013-07-03 |
2016-08-05 |
豪夫迈.罗氏有限公司 |
杂芳基吡啶酮和氮杂-吡啶酮酰胺化合物
|
|
JP6084292B2
(ja)
|
2013-07-18 |
2017-02-22 |
大鵬薬品工業株式会社 |
Fgfr阻害剤耐性癌の治療薬
|
|
EP3628749A1
(en)
|
2013-07-30 |
2020-04-01 |
Blueprint Medicines Corporation |
Ntrk2 fusions
|
|
WO2015017528A1
(en)
|
2013-07-30 |
2015-02-05 |
Blueprint Medicines Corporation |
Pik3c2g fusions
|
|
ES3069593T3
(en)
|
2013-08-23 |
2026-06-09 |
Neupharma Inc |
Quinazolin-8-yl derivatives for use in methods of treating melanoma, non-small cell lung cancer, thyroid cancer, ovarian cancer, or colon cancer
|
|
US10323285B2
(en)
|
2013-09-09 |
2019-06-18 |
Nantomics, Llc |
Proteomics analysis and discovery through DNA and RNA sequencing, systems and methods
|
|
RU2650512C2
(ru)
|
2013-09-18 |
2018-04-16 |
Бейджин Ханми Фармасьютикал Ко., Лтд. |
Соединение, ингибирующее активности киназ ВТК и/или JAK3
|
|
CN105792844B
(zh)
|
2013-10-08 |
2021-03-02 |
第一三共株式会社 |
抗fgfr2抗体和另一药剂的组合
|
|
MX365614B
(es)
|
2013-10-17 |
2019-06-07 |
Blueprint Medicines Corp |
Composiciones utiles para tratar trastornos relacionados con kit.
|
|
US9334263B2
(en)
|
2013-10-17 |
2016-05-10 |
Blueprint Medicines Corporation |
Compositions useful for treating disorders related to kit
|
|
PT3395814T
(pt)
|
2013-10-25 |
2022-07-27 |
Blueprint Medicines Corp |
Inibidores do recetor do fator de crescimento de fibroblastos
|
|
CN105793251B
(zh)
|
2013-12-05 |
2018-10-12 |
豪夫迈·罗氏有限公司 |
具有亲电子官能性的杂芳基吡啶酮和氮杂-吡啶酮化合物
|
|
EP3089970B1
(en)
|
2013-12-09 |
2018-10-17 |
AbbVie Inc. |
Dihydropyridinone and dihydropyridazinone derivatives useful as bromodomain inhibitors
|
|
IL274464B2
(en)
|
2013-12-11 |
2023-08-01 |
Accuragen Holdings Ltd |
Preparations and methods for the detection of rare sequence variants
|
|
WO2015099127A1
(ja)
|
2013-12-27 |
2015-07-02 |
中外製薬株式会社 |
Fgfrゲートキーパー変異遺伝子およびそれを標的とする医薬
|
|
WO2015108992A1
(en)
|
2014-01-15 |
2015-07-23 |
Blueprint Medicines Corporation |
Heterobicyclic compounds and their use as fgfr4 receptor inhibitors
|
|
CN103772352B
(zh)
|
2014-01-16 |
2017-01-18 |
四川百利药业有限责任公司 |
哒嗪酮类衍生物及其制备方法和用途
|
|
WO2015112806A2
(en)
|
2014-01-24 |
2015-07-30 |
Tp Therapeutics, Inc. |
Diaryl macrocycles as modulators of protein kinases
|
|
US20160340742A1
(en)
|
2014-02-04 |
2016-11-24 |
Mayo Foundation For Medical Education And Research |
Method of Identifying Tyrosine Kinase Receptor Rearrangements in Patients
|
|
DK3102577T3
(en)
|
2014-02-07 |
2018-11-12 |
Principia Biopharma Inc |
QUINOLONDERIVATIVES AS FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITORS
|
|
US10231965B2
(en)
|
2014-02-20 |
2019-03-19 |
Ignyta, Inc. |
Molecules for administration to ROS1 mutant cancer cells
|
|
BR112016022056B1
(pt)
|
2014-03-26 |
2023-04-11 |
Astex Therapeutics Limited |
Combinação, composição farmacêutica, uso de uma combinação ou uma composição farmacêutica, e, produto farmacêutico
|
|
JO3512B1
(ar)
|
2014-03-26 |
2020-07-05 |
Astex Therapeutics Ltd |
مشتقات كينوكسالين مفيدة كمعدلات لإنزيم fgfr كيناز
|
|
WO2015150900A2
(en)
|
2014-03-31 |
2015-10-08 |
Debiopharm International Sa |
Fgfr fusions
|
|
WO2015160636A1
(en)
|
2014-04-16 |
2015-10-22 |
Merck Sharp & Dohme Corp. |
Factor ixa inhibitors
|
|
WO2015160634A1
(en)
|
2014-04-16 |
2015-10-22 |
Merck Sharp & Dohme Corp. |
Factor ixa inhibitors
|
|
WO2015161274A1
(en)
|
2014-04-18 |
2015-10-22 |
Blueprint Medicines Corporation |
Pik3ca fusions
|
|
US20170044621A1
(en)
|
2014-04-18 |
2017-02-16 |
Blueprint Medicines Corporation |
Met fusions
|
|
CN106459013B
(zh)
|
2014-05-15 |
2019-10-25 |
阵列生物制药公司 |
作为trka激酶抑制剂的化合物及其用途
|
|
EA028614B1
(ru)
|
2014-05-22 |
2017-12-29 |
Общество С Ограниченной Ответственностью "Русские Фармацевтические Технологии" |
Селективные ингибиторы, нарушающие взаимодействие рецептора фактора роста фибробластов и frs2, для профилактики и лечения рака
|
|
EP3155131B1
(en)
|
2014-06-10 |
2020-02-12 |
Blueprint Medicines Corporation |
Raf1 fusions
|
|
WO2015191667A1
(en)
|
2014-06-10 |
2015-12-17 |
Blueprint Medicines Corporation |
Pkn1 fusions
|
|
WO2015193740A2
(en)
|
2014-06-17 |
2015-12-23 |
Acerta Pharma B.V. |
Therapeutic combinations of a btk inhibitor, a pi3k inhibitor and/or a jak-2 inhibitor
|
|
US10370724B2
(en)
|
2014-07-17 |
2019-08-06 |
Blueprint Medicines Corporation |
PRKC fusions
|
|
WO2016011144A1
(en)
|
2014-07-17 |
2016-01-21 |
Blueprint Medicines Corporation |
Tert fusions
|
|
EP3169804B3
(en)
|
2014-07-17 |
2019-09-18 |
Blueprint Medicines Corporation |
Fgr fusions
|
|
US9688680B2
(en)
|
2014-08-04 |
2017-06-27 |
Blueprint Medicines Corporation |
Compositions useful for treating disorders related to kit
|
|
HUE045237T2
(hu)
|
2014-08-18 |
2019-12-30 |
Ono Pharmaceutical Co |
TRK-inhibitáló vegyület savaddíciós sója
|
|
CN107427524A
(zh)
|
2014-08-28 |
2017-12-01 |
翁科埃斯克斯有限公司 |
利用包含噻吩并三唑并二氮杂*化合物的药物组合物治疗急性髓细胞白血病或急性淋巴性白血病的方法
|
|
JP6636014B2
(ja)
|
2014-09-12 |
2020-01-29 |
ノバルティス アーゲー |
Rafキナーゼ阻害剤としての化合物および組成物
|
|
EP3218378B1
(en)
|
2014-11-14 |
2020-01-08 |
Nerviano Medical Sciences S.r.l. |
6-amino-7-bicyclo-7-deaza-purine derivatives as protein kinase inhibitors
|
|
TWI746426B
(zh)
|
2014-11-16 |
2021-11-21 |
美商亞雷生物製藥股份有限公司 |
(S)-N-(5-((R)-2-(2,5-二氟苯基)-吡咯啶-1-基)-吡唑并[1,5-a]嘧啶-3-基)-3-羥基吡咯啶-1-甲醯胺硫酸氫鹽結晶型
|
|
US20170356052A1
(en)
|
2014-11-18 |
2017-12-14 |
Blueprint Medicines Corporation |
Prkacb fusions
|
|
JP2018027019A
(ja)
|
2014-11-26 |
2018-02-22 |
国立研究開発法人国立がん研究センター |
胆道がんにおける新規治療標的融合遺伝子
|
|
AU2015371312B2
(en)
|
2014-12-24 |
2022-01-27 |
Genentech, Inc. |
Therapeutic, diagnostic and prognostic methods for cancer of the bladder
|
|
US9909016B2
(en)
|
2015-02-28 |
2018-03-06 |
Matthew Fontaine |
Elastomeric coating composition
|
|
WO2016139227A1
(en)
|
2015-03-03 |
2016-09-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Fgfr3 antagonists
|
|
US10538517B2
(en)
|
2015-05-22 |
2020-01-21 |
Principia Biopharma, Inc. |
Quinolone derivatives as FGFR inhibitors
|
|
EP3355808B1
(en)
|
2015-10-02 |
2022-11-16 |
Flexdex, Inc. |
Handle mechanism providing unlimited roll
|
|
EP3365335B1
(en)
|
2015-10-23 |
2024-02-14 |
Array Biopharma, Inc. |
2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2h)-one compounds as inhibitors of fgfr tyrosine kinases
|
|
US9640210B1
(en)
|
2015-11-13 |
2017-05-02 |
Kabushiki Kaisha Toshiba |
Virtual window mode for guide spiral servo demodulation
|
|
JP6751977B2
(ja)
|
2016-09-01 |
2020-09-09 |
南京薬捷安康生物科技有限公司 |
線維芽細胞増殖因子受容体の阻害剤及びそれらの使用
|
|
CN107840842A
(zh)
|
2016-09-19 |
2018-03-27 |
北京天诚医药科技有限公司 |
炔代杂环化合物、其制备方法及其在医药学上的应用
|
|
CN108082275B
(zh)
|
2016-11-23 |
2021-08-24 |
操纵技术Ip控股公司 |
电动转向系统
|
|
RU2747260C2
(ru)
|
2016-12-19 |
2021-04-29 |
Аббиско Тхерапеутицс Цо., Лтд. |
Ингибитор рфрф4, способ его получения и его фармацевтическое применение
|
|
CN108456163A
(zh)
|
2017-02-20 |
2018-08-28 |
中国科学院上海药物研究所 |
含邻氨基杂芳环炔基的化合物及其制备方法和用途
|
|
MA47408B1
(fr)
*
|
2017-12-20 |
2023-08-31 |
Janssen Pharmaceutica Nv |
Traitement du cancer
|